Cipla
Kunica A. is currently serving as a Mergers and Acquisitions Manager at Cipla since September 2023. Prior to this role, Kunica was part of the Investment Team at Masters Union Investment Fund from September 2022 to September 2023, where involvement included managing a student-run fund with a seed corpus of INR 5 Crore and investments across various asset classes. Previous experience includes working as an Associate at PwC India from May 2021 to May 2022, specializing as an SAP FICO Functional Consultant, where significant contributions included process automation and system design for companies in the pharmaceutical and real estate sectors. Kunica's earlier experience as an Articled Assistant at ATMS & CO LLP spans from February 2017 to February 2020. Educational qualifications include a Postgraduate degree in Business and Technology from Masters' Union, Chartered Accountant certification from The Institute of Chartered Accountants of India, and ongoing studies with ACCA, alongside a Bachelor of Commerce degree from Birla College of Arts Science & Commerce.
This person is not in any teams
This person is not in any offices
Cipla
19 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.